Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
Background: Parkinson's disease (PD) is a disease of ⍺-synuclein aggregation-mediated dopaminergic neuronal loss in the substantia nigra pars compacta, which leads to motor and non-motor symptoms. Through the last two decades of research, there has been growing consensus that inflammation-media...
Main Authors: | Safa Salim, Fatima Ahmad, Ayesha Banu, Farhan Mohammad |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Journal of Advanced Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090123222002429 |
Similar Items
-
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
by: Han-Lin Chiang, et al.
Published: (2019-05-01) -
The Microbiome-Gut-Brain Axis, Nutrition and Parkinson’s Disease
by: Jevgenija Guk, et al.
Published: (2024-03-01) -
Microbiome, Parkinson’s Disease and Molecular Mimicry
by: Fabiana Miraglia, et al.
Published: (2019-03-01) -
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
by: Cristiana Vilela, et al.
Published: (2024-04-01) -
Regulation of gut microbiome by ketogenic diet in neurodegenerative diseases: A molecular crosstalk
by: Shobana Kaviyarasan, et al.
Published: (2022-10-01)